DUVELISIB | DUVELISIB | ATC L01EM04
ANTINEOPLASTIC PI3K DELTA AND PI3K GAMMA KINASE INHIBITOR TREATMENT OF REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) | ORAL | Cmax 3.6 MICROMOLAR Tmax 1.5 HOUR F 42 PERCENT VD 28.5 LITER PPB 98 PERCENT Cl 4.2 LITER / HOUR HT 4.7 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | PI3K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform UNIPROT O00329 PIK3CD -- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform UNIPROT P48736 PIK3CG more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |